Minerva Neurosciences Inc. buy DomRuinart
Start price
05.01.26
/
50%
€3.46
Target price
05.01.27
€5.50
Performance (%)
2.89%
Price
07:45
?
Summary
This prediction is currently active. The BUY prediction by DomRuinart shows slight gains of 2.89%. This prediction currently runs until 05.01.27. The prediction end date can be changed by DomRuinart at any time. DomRuinart has 50% into this predictionMinerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Minerva Neurosciences Inc. | 2.89% |
| iShares Core DAX® | 2.032% |
| iShares Nasdaq 100 | -0.145% |
| iShares Nikkei 225® | 4.507% |
| iShares S&P 500 | 0.331% |
According to DomRuinart what are the pros and cons of Minerva Neurosciences Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by DomRuinart for this prediction
In the thread Minerva Neurosciences Inc. diskutieren
Stopped prediction by DomRuinart for Minerva Neurosciences Inc.
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.64
19.09.22
19.09.22
€17.00
19.09.23
19.09.23
-34.41%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
